Cyclo(-Arg-Gly-Asp-D-Phe-Lys) trifluoroacetate

CAS : 500577-51-5

Ref. 3D-FC110054

Informations sur le produit

• Nom: Cyclo(-Arg-Gly-Asp-D-Phe-Lys) trifluoroacetate
• CAS: 500577-51-5

Description

Cyclo(-Arg-Gly-Asp-D-Phe-Lys) trifluoroacetate is a cyclic peptide that has been shown to be an effective chemotherapeutic agent against bladder cancer. Cyclo(-Arg-Gly-Asp-D-Phe-Lys) trifluoroacetate binds to the integrin receptor on the tumor cell surface and blocks the formation of new blood vessels, which may lead to tumor growth inhibition. The hypoxic tumor environment is characterized by low oxygen levels, which causes the mitochondria in cells to produce more hydrogen peroxide. Cyclo(-Arg-Gly-Asp-D-Phe-Lys) trifluoroacetate has been shown to decrease the production of hydrogen peroxide in hypoxic tumors. This drug also inhibits angiogenesis and cellular proliferation.
Cyclo(-Arg-Gly-Asp) trifluoroacetate has

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 717.7 g/mol
• Formule: C₂₇H₄₁N₉O₇•C₂HF₃O₂
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: White Off-White Powder